Skip to content
HowShorted

How shorted is Xeris Biopharma Holdings, Inc.? XERS

#1,883most shorted US stockof 3,805 ranked stocks, more shorted than 50%

The ticker XERS previously referred to XERIS PHARMACEUTICALS INC (to 2021).

4.42%
of shares outstanding reported short · settlement date 15 Sep 2026
vs previous report
+0.01
5 reports (~10 weeks)
−2.97
days to cover
4.83
Aggregate net short position time series for Xeris Biopharma Holdings, Inc.

Markers along the chart's base: ▲ results announced (an 8-K reporting results was filed) ▲ quarterly or annual report filed. Dates are SEC filing dates; hover a point to see events since the previous settlement.

Days to cover

FINRA's own figure: reported shares short divided by the stock's average daily trading volume, published alongside each settlement. It expresses the short position in days of typical trading rather than as a percentage of the company; the two can move differently.

Aggregate net short position time series for Xeris Biopharma Holdings, Inc. days to cover

Short interest around results

For each results announcement (an 8-K reporting results, by its SEC filing date), the FINRA settlement before it and the first one after. Settlements fall twice a month, so the two figures can sit up to a month apart and much else changes in between: this shows what was reported, not why.

Reported short interest before and after each results announcement
Results filedSettlement beforeSettlement afterChange
6 Aug 20265.06% 31 Jul 20264.79% 14 Aug 2026−0.27
7 May 20269.21% 30 Apr 20267.16% 15 May 2026−2.05
2 Mar 202610.25% 27 Feb 20269.78% 13 Mar 2026−0.47
8 Jan 20269.96% 31 Dec 202510.18% 15 Jan 2026+0.22
6 Nov 202510.62% 31 Oct 20259.49% 14 Nov 2025−1.13
7 Aug 202511.28% 31 Jul 20258.27% 15 Aug 2025−3.01
8 May 202510.76% 30 Apr 202511.12% 15 May 2025+0.36
6 Mar 20257.13% 28 Feb 20257.52% 14 Mar 2025+0.39

Fails to deliver

The SEC's fails-to-deliver figure for XERS: the aggregate net balance of shares that failed to be delivered at each settlement date, published by the SEC twice a month and shown here verbatim for the trailing window. A balance is not a daily flow, and a fail has many ordinary causes; the SEC says it cannot guarantee the accuracy of the data. See what fails to deliver are and the largest balances today.

Last balance on file
21
8 Sep 2026
Highest in window
50,000
14 Jul 2026
Days with a balance
29
Window
16 Sep 2025 to 14 Sep 2026
Aggregate net short position time series for Xeris Biopharma Holdings, Inc. fails to deliver

Source: U.S. Securities and Exchange Commission, fails-to-deliver data (public domain). Only settlement days with a positive balance appear; the largest balance in the window was 50K shares.

Embed this chart

Paste this snippet to embed the interactive chart. It updates with each FINRA report and keeps the source attribution. Preview

Download chart cardShare on XRedditLinkedIn
Cite this page
Plain
Wikipedia
BibTeX

Sector: Healthcare

History

Full reported short interest history
Settlement dateShort %Change
15 Sep 20264.42%+0.01
31 Aug 20264.41%−0.38
14 Aug 20264.79%−0.27
31 Jul 20265.06%−0.78
15 Jul 20265.84%−1.55
30 Jun 20267.39%−0.03
15 Jun 20267.42%+0.17
29 May 20267.25%+0.09
15 May 20267.16%−2.05
30 Apr 20269.21%−0.28
15 Apr 20269.49%−0.40
31 Mar 20269.89%+0.11
13 Mar 20269.78%−0.47
27 Feb 202610.25%−0.23
13 Feb 202610.48%+0.24
30 Jan 202610.24%+0.06
15 Jan 202610.18%+0.22
31 Dec 20259.96%+0.66
15 Dec 20259.30%−0.33
28 Nov 20259.63%+0.14
14 Nov 20259.49%−1.13
31 Oct 202510.62%−0.43
15 Oct 202511.05%+0.25
30 Sep 202510.80%+0.74
15 Sep 202510.06%+0.95
29 Aug 20259.11%+0.84
15 Aug 20258.27%−3.01
31 Jul 202511.28%−0.93
15 Jul 202512.21%−0.26
30 Jun 202512.47%+1.27
13 Jun 202511.20%+0.21
30 May 202510.99%−0.13
15 May 202511.12%+0.36
30 Apr 202510.76%−2.02
15 Apr 202512.78%+1.35
31 Mar 202511.43%+3.91
14 Mar 20257.52%+0.39
28 Feb 20257.13%+0.24
14 Feb 20256.89%−0.14
31 Jan 20257.03%+0.08
15 Jan 20256.95%+0.12
31 Dec 20246.83%+0.45
13 Dec 20246.38%−0.27
29 Nov 20246.65%−0.16
15 Nov 20246.81%−0.82
31 Oct 20247.63%−0.13
15 Oct 20247.76%+0.31
30 Sep 20247.45%+0.07
13 Sep 20247.38%+0.19
30 Aug 20247.19%−0.06
15 Aug 20247.25%−0.28
31 Jul 20247.53%−0.17
15 Jul 20247.70%+0.28
28 Jun 20247.42%−0.06
14 Jun 20247.48%−0.16
31 May 20247.64%+0.36
15 May 20247.28%+0.78
30 Apr 20246.50%+0.03
15 Apr 20246.47%−0.03
28 Mar 20246.50%−0.19
15 Mar 20246.69%−0.29
29 Feb 20246.98%+0.16
15 Feb 20246.82%+0.02
31 Jan 20246.80%−0.73
12 Jan 20247.53%+0.58
29 Dec 20236.95%+1.07
15 Dec 20235.88%−0.07
30 Nov 20235.95%−0.53
15 Nov 20236.48%+0.84
31 Oct 20235.64%+0.13
13 Oct 20235.51%−0.24
29 Sep 20235.75%+0.05
15 Sep 20235.70%+0.32
31 Aug 20235.38%−0.79
15 Aug 20236.17%+0.16
31 Jul 20236.01%−0.19
14 Jul 20236.20%+0.02
30 Jun 20236.18%−0.33
15 Jun 20236.51%+0.78
31 May 20235.73%−0.34
15 May 20236.07%−0.17
28 Apr 20236.24%+0.37
14 Apr 20235.87%+0.12
31 Mar 20235.75%−0.34
15 Mar 20236.09%+1.05
28 Feb 20235.04%+0.60
15 Feb 20234.44%−0.33
31 Jan 20234.77%+0.39
13 Jan 20234.38%+0.08
30 Dec 20224.30%+0.11
15 Dec 20224.19%−0.03
30 Nov 20224.22%−0.44
15 Nov 20224.66%+0.03
31 Oct 20224.63%+0.04
14 Oct 20224.59%−0.26
30 Sep 20224.85%−1.34
15 Sep 20226.19%−0.55
31 Aug 20226.74%−0.34
15 Aug 20227.08%−0.55
29 Jul 20227.63%+0.35
15 Jul 20227.28%−0.25
30 Jun 20227.53%+2.96
15 Jun 20224.57%−0.42
31 May 20224.99%+0.41
13 May 20224.58%+0.24
29 Apr 20224.34%+0.74
14 Apr 20223.60%+0.40
31 Mar 20223.20%−0.98
15 Mar 20224.18%−0.07
28 Feb 20224.25%−0.89
15 Feb 20225.14%−0.19
31 Jan 20225.33%+1.57
14 Jan 20223.76%–

Newest first. Scroll inside the table for earlier dates, back to 14 Jan 2022.

Frequently asked questions

How shorted is Xeris Biopharma Holdings, Inc. right now?
4.42% of Xeris Biopharma Holdings, Inc.'s (XERS) shares outstanding were reported short for settlement date 15 Sep 2026, per FINRA's consolidated short interest report. That makes it the 1,883rd most shorted US stock, out of 3,805 we rank.
What does this number include?
FINRA member firms must report their short positions in all US equities twice a month; FINRA consolidates them per security. We divide that official share count by the company's shares outstanding from its SEC filings. This is the regulatory figure, not a daily estimate.
Why does it only update twice a month?
US short interest is reported for settlement on the 15th and the last business day of each month, and FINRA publishes the consolidated figures about nine business days later. That cadence is set by regulation; no daily official figure exists.
Is this XERS's short float?
No. This is short interest as a percentage of shares outstanding, the count in the company's SEC filings. "Short float" divides the same FINRA short count by the public float, which excludes closely held shares, so it comes out higher for the same company. We publish no float estimates: the float is not a regulatory figure.
What is XERS's days to cover?
4.83 days for settlement date 15 Sep 2026: FINRA's own short interest ratio, the reported shares short divided by average daily trading volume. It is published in the same FINRA file and shown verbatim; we hold no volume data ourselves.
Which funds are short?
US public short interest is aggregate-only: individual short sellers are not named. Only some EU markets publish named positions.